The Latest Breaking News from Vaccine

Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business

UK Health Security Agency (UKHSA) has issued a strong call to action, urging eligible individuals, especially those from ethnic minority groups, to book their flu and COVID-19 vaccines.

The African-led trial was initiated in December 2020 but came to an early halt last month. Its conclusive findings are to be released in 2024.

You may have read recent alarming reports of a cough that “lasts 100 days” is “quickly spreading across the UK” and can “fracture ribs”. If you didn’t look beyond the headlines, you might have missed the fact that the reports are about whooping cough.

Two new COVID-19 vaccines targeting the new Omicron variant of the virus are now available in Australian pharmacies around the nation.

Special medical camps held in cyclone-affected districts of TN screen 1.3L; MR vaccine advised for children in flood-hit areas. Health Minister launched camps in 679 places, 200 each in Tiruvallur & Chengalpattu, 100 in Kancheepuram. Screening for dengue, chikungunya, diarrhoea, sore throat & cough; MR vaccine advised for children in…

Scientists have offered a new explanation for why COVID-19 vaccines that contained adenoviruses carried a rare-but-serious risk of blood clotting.

Data shows increase in infections and experts advise vaccination for pregnant women, babies and young children

At The Union World Conference on Lung Health, optimism abounded as new drug regimens were presented that could cut treatment time for drug-resistant TB by up to two-thirds. These regimens, with 85-90% success rates, offer hope to those affected by MDR-TB, who often face long treatments and 14,000 pills. Funding…

African-led trial ended a year early as researchers conclude there is ‘little or no chance’ new combination vaccines cut HIV risk

A new vaccine, so far tested only in mice, broadly activates the immune system against a wide array of bacteria and fungi.